{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:04:55Z","timestamp":1789193095496,"version":"build-2803163510"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0150565","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T13:43:49Z","timestamp":1458567829000},"page":"e0150565","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Preterm Birth and Low Birth Weight after In Utero Exposure to Antiretrovirals Initiated during Pregnancy in Yaound\u00e9, Cameroon"],"prefix":"10.1371","volume":"11","author":[{"given":"Anne Esther","family":"Njom Nlend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Nga Motaz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzie","family":"Moyo Tetang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Zeudja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Ngantcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathurin","family":"Tejiokem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"key":"ref1","first-page":"171","article-title":"Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial","volume":"3","author":"I de Vincenzi","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref2","year":"2011"},{"key":"ref3","unstructured":"World Health Organization (2010) Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommandations for a public health approach. Geneva."},{"key":"ref4","year":"2009"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/tropej\/fmr100","article-title":"Early outcomes of HIV exposed children in the first district-wide programme using extended regimens for the prevention of mother-to-child transmission of HIV, in Yaounde, Cameroon","volume":"4","author":"A E Njom Nlend","year":"2012","journal-title":"J Trop Pediatr"},{"key":"ref6","first-page":"198","article-title":"Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy","volume":"4","author":"J F Senise","year":"2011","journal-title":"AIDS Rev"},{"key":"ref7","first-page":"2337","article-title":"Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe","volume":"17","author":"C Thorne","year":"2004","journal-title":"Aids"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/QAD.0b013e32830b8ab9","article-title":"Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Cote d'Ivoire","volume":"14","author":"D K Ekouevi","year":"2008","journal-title":"Aids"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e1525","DOI":"10.1542\/peds.2011-2340","article-title":"Infant outcomes after maternal antiretroviral exposure in resource-limited settings","volume":"6","author":"K Nielsen-Saines","year":"2012","journal-title":"Pediatrics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00404-009-1186-x","article-title":"Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria","volume":"6","author":"B N Olagbuji","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"ref11","first-page":"51","article-title":"Combination antiretroviral therapy with protease inhibitors in HIV-infected pregnancy","volume":"1","author":"C P Dola","year":"2011","journal-title":"J Perinat Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/infdis\/jis581","article-title":"Antiretrovirals in pregnancy: a note of caution","volume":"11","author":"D HL Watts","year":"2012","journal-title":"J Infect Dis"},{"key":"ref13","first-page":"31","article-title":"Antiretroviral therapy and pregnancy outcomes in developing countries: A systematic review","volume":"1","author":"Alemu","year":"2013","journal-title":"International Journal"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/apc.2012.0401","article-title":"Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India","volume":"3","author":"S Darak","year":"2013","journal-title":"AIDS Patient Care STDS"},{"key":"ref15","first-page":"CD008440","article-title":"Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women","volume":"3","author":"A S Sturt","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jiu393","article-title":"HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction","volume":"1","author":"E Papp","year":"2015","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/651232","article-title":"Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy","volume":"7","author":"K Patel","year":"2010","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/jir307","article-title":"Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy","volume":"4","author":"K M Powis","year":"2011","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0036-46652015000200003","article-title":"Preterm birth and fetal growth restriction in HIV-infected Brazilian pregnant women","volume":"2","author":"H L Dos Reis","year":"2015","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/infdis\/jis553","article-title":"Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana","volume":"11","author":"J Y Chen","year":"2012","journal-title":"J Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/QAD.0b013e32832be0df","article-title":"No relation between in-utero exposure to HAART and intrauterine growth retardation","volume":"10","author":"N Briand","year":"2009","journal-title":"Aids"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1097\/INF.0000000000000712","article-title":"Antiretroviral Therapy Use During Pregnancy and the Risk of Small for Gestational Age Birth in a Medicaid Population","volume":"7","author":"K Phiri","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1758-2652-14-42","article-title":"Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study","author":"K Van der Merwe","year":"2011","journal-title":"J Int AIDS Soc"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e41934","DOI":"10.1371\/journal.pone.0041934","article-title":"Maternal nutritional status predicts adverse birth outcomes among HIV-infected rural Ugandan women receiving combination antiretroviral therapy","volume":"8","author":"S Young","year":"2012","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/QAI.0000000000000686","article-title":"HIV, Antiretroviral Therapy, and Hypertensive Disorders in Pregnancy: A Systematic Review and Meta-analysis","volume":"1","author":"J L Browne","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref26","article-title":"Small-for-gestational-age births in pregnant women with HIV, due to severity of HIV disease, not antiretroviral therapy","author":"E Aaron","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1272\/jnms.80.90","article-title":"Role of the placenta in adverse perinatal outcomes among HIV-1 seropositive women","volume":"2","author":"W tJ Ackerman","year":"2013","journal-title":"J Nippon Med Sch"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/humrep\/des090","article-title":"Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa","volume":"6","author":"J Ndirangu","year":"2012","journal-title":"Hum Reprod"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/QAI.0b013e3182a2d13c","article-title":"Severity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study","volume":"4","author":"A N Turner","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/QAD.0b013e3283493ed0","article-title":"Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes","volume":"13","author":"M C Marazzi","year":"2011","journal-title":"Aids"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/14740338.2015.1019462","article-title":"Tolerance of the newborn to antiretroviral drug exposure in utero","volume":"5","author":"J Sibiude","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/EDE.0000000000000317","article-title":"A Simple Regression-based Approach to Account for Survival Bias in Birth Outcomes Research","volume":"4","author":"E J Tchetgen Tchetgen","year":"2015","journal-title":"Epidemiology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0150565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T19:40:55Z","timestamp":1540237255000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0150565"}},"subtitle":[],"editor":[{"given":"Clive M.","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0150565","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]}}}